Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial

Citation
Verma S, Bain SC, Bus JB, et al. JAMA Cardiol 2019;4:1214–20.